Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).

Nicklas, André P

Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC). [electronic resource] - Advances in therapy 11 2018 - 2054-2068 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1865-8652

10.1007/s12325-018-0789-7 doi


Aged
Biomarkers, Tumor--analysis
Calcium-Binding Proteins--analysis
Calgranulin A--analysis
Disease Progression
Female
Humans
Immunohistochemistry
Male
Neoplasm Grading
Neoplasm Invasiveness--diagnosis
Neoplasm Recurrence, Local--diagnosis
Prognosis
Reproducibility of Results
Retrospective Studies
Risk Assessment--methods
Urinary Bladder Neoplasms--diagnosis